Article
Resistance to Linezolid Caused by Modifications at Its Binding Site on the Ribosome
6 Dec 2011
Abstract excerpt
Linezolid is an oxazolidinone antibiotic in clinical use for the treatment of serious infections of resistant Gram-positive bacteria. It inhibits protein synthesis by binding to the peptidyl transferase center on the ribosome. Almost all known resistance mechanisms involve small alterations to the linezolid binding site, so this review will therefore focus on the various changes that can adversely affect drug...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
